from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1059/-

LFCtreatmentdescriptionclass of inhibitor

1.069

Amikacinug/mL Amikacintranslation

0.617

Cap5-10ug/mL Capreomycintranslation

0.856

Rox10-50 ug/mL Roxithromycintranslation

0.696

SM2-5 ug/mL Streptomycintranslation

1.767

Tet5-10 ug/mL Tetracyclinetranslation

0.068

Rif0.2-5ug/mL Rifampicintranscription

-0.516

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.616

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.202

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.318

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.156

Clofazimine10-13 ug/mL Clofaziminerespiration

0.371

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.659

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.036

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.526

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.950

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.143

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.157

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.182

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.536

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.659

KCN5-20 ug/mL Potassium cyaniderespiration

-0.856

NaN30.2-2 mM Sodium aziderespiration

-1.395

Nigericin50 uM Nigericinrespiration

-0.416

TRC10-150 ug/mL Triclosanrespiration

-1.281

TRZ10-25 ug/mL Thioridazinerespiration

-1.066

Valinomycin0.5-10 uM Valinomycinrespiration

-0.408

ZnSO42 mM ZnSO4respiration

-0.653

menadione6-10 ug/mL Menadionerespiration

-0.375

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.350

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.066

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.634

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.105

NRP_1Non-replicating persistence stage 1dosRassociated

0.291

Amp0.2mg/mL AmpicillincellWall

-0.249

Cephalexin20-100 ug/mL CephalexincellWall

0.537

Cerulenin0.32-5 ug/mL CerulenincellWall

0.115

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.160

EMB10-20 ug/mL EthambutolcellWall

0.510

Eta12-40 ug/mL EthionamidecellWall

0.550

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.048

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.519

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.039

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.197

BZA0.12 mg/mL BenzamidearomaticAmides

0.245

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.417

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.164

H2O24 mM hydrogen peroxideDNAdamaging

-0.095

Levo10 ug/mL LevofloxacinDNAdamaging

0.187

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.699

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.504

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.170

UVUV-irradiationDNAdamaging

-1.854

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.563

Antimycin12.5-50 ug/mL Antimycin A?

-0.594

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.042

PA_110-50 ug/mL Antitubercular compound PA-1?

0.460

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.846

PA8240.2-2 ug/mL PA-824?

0.302

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.941

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.077

Verapamil50 uM Verapamil?

-0.250

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.920

methoxatin10-20 ug/mL Methoxatin?